US2018030207A1PendingUtilityA1
Linear cyclodextrin copolymers
Est. expiryJul 1, 2018(expired)· nominal 20-yr term from priority
C08G 69/48C08B 37/0012A61K 47/6951B82Y 5/00C08G 73/06C08G 69/40C08G 73/02C08G 75/06
71
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Linear cyclodextrin copolymers and linear oxidized cyclodextrin copolymers containing an unoxidized and/or an oxidized cyclodextrin moiety integrated into the polymer backbone are described. Methods of preparing such copolymers are also described. The linear cyclodextrin copolymer and linear oxidized cyclodextrin copolymer of the invention may be used as a delivery vehicle of various therapeutic agents.
Claims
exact text as granted — not AI-modifiedThe claimed invention is:
1 . A linear cyclodextrin copolymer comprising a repeating unit of formula Ia, Ib, or a combination thereof:
wherein C is a substituted or unsubstituted cyclodextrin monomer and A is a comonomer bound to cyclodextrin C.
2 . A cyclodextrin copolymer of claim 1 , wherein said cyclodextrin monomer is an α-, β-, γ-cyclodextrin, or combination thereof.
3 . A cyclodextrin copolymer of claim 1 , wherein said cyclodextrin monomer has the general formula (II):
and is selected from the group consisting of: 6 A ,6 B -deoxy-α-cyclodextrin (n=0, m=4), 6 A ,6 C -deoxy-α-cyclodextrin (n=1, m=3), 6 A ,6 D -deoxy-α-cyclodextrin (n=2, m=2), 6 A ,6 B -deoxy-β-cyclodextrin (n=0, m=5), 6 A ,6 C -deoxy-β-cyclodextrin (n=1, m=4), 6 A -6 C -deoxy-β-cyclodextrin (n=2, m=3), 6 A ,6 B -deoxy-γ-cyclodextrin (n=0, m=6), 6 A ,6 C -deoxy-γ-cyclodextrin (n=1, m=5), 6 A ,6 D -deoxy-γ-cyclodextrin (n=2, m=4), and 6 A ,6 E -deoxy-γ-cyclodextrin (n=3, m=3).
4 . A cyclodextrin copolymer of claim 1 , wherein said cyclodextrin monomer has the general formula (III):
where p=5-7.
5 . A cyclodextrin copolymer of claim 4 , wherein said cyclodextrin monomer is selected from the group consisting of 2 A ,3 A -deoxy-2 A ,3 A -dihydro-α-cyclodextrin, 2 A ,3 A -deoxy-2 A ,3 A -dihydro-β-cyclodextrin, and 2 A ,3 A -deoxy-2 A ,3 A -dihydro-γ-cyclodextrin.
6 . A cyclodextrin copolymer of claim 1 , wherein A is selected from the group consisting of:
where x=1-50, and y+z=x.
7 . A cyclodextrin copolymer of claim 1 , wherein A is biodegradable or acid-labile.
8 . A cyclodextrin copolymer of claim 1 , wherein the cyclodextrin copolymer is crosslinked to a polymer.
9 . A cyclodextrin copolymer of claim 8 , wherein at least one ligand is bound to the linear cyclodextrin copolymer.
10 . A cyclodextrin copolymer of claim 1 , wherein at least one ligand is bound to the linear cyclodextrin copolymer.
11 . A cyclodextrin copolymer of claim 1 , wherein at least one cyclodextrin monomer C is oxidized.
12 . A cyclodextrin copolymer of claim 11 , wherein said cyclodextrin monomer is an α-, β-, γ-cyclodextrin, or combination thereof.
13 . A cyclodextrin copolymer of claim 11 , wherein the cyclodextrin copolymer is crosslinked to a polymer.
14 . A cyclodextrin copolymer of claim 13 , wherein at least one ligand is bound to the linear oxidized cyclodextrin copolymer.
15 . A cyclodextrin copolymer of claim 11 , wherein at least one ligand is bound to the linear oxidized cyclodextrin copolymer.
16 . A cyclodextrin copolymer of claim 1 , wherein substantially all of the cyclodextrin monomers are oxidized.
17 . A cyclodextrin copolymer of claim 1 , wherein all of the cyclodextrin monomers are oxidized.
18 . A therapeutic composition comprising a cyclodextrin copolymer of claim 1 , 8 , 9 , 10 , 11 , 13 , 14 or 15 and a therapeutic agent.
19 . A cyclodextrin composition comprising:
a first linear cyclodextrin polymer comprising a repeating unit of formula Ia, Ib, or a combination thereof:
wherein C is a substituted or unsubstituted cyclodextrin monomer and A is a comonomer bound to cyclodextrin C; and
a second linear cyclodextrin copolymer comprising a repeating unit of formula Ia, Ib, or a combination thereof wherein at least one cyclodextrin monomer C of said second linear cyclodextrin copolymer is oxidized.
20 . A composition of claim 19 , wherein at least one of said first linear cyclodextrin copolymer and said second linear cyclodextrin copolymer is crosslinked to another polymer.
21 . A composition of claim 20 , wherein at least one ligand is bound to at least one of said first linear cyclodextrin copolymer and said second linear cyclodextrin copolymer.
22 . A composition of claim 19 , wherein at least one ligand is bound to at least one of said first linear cyclodextrin copolymer and said second linear cyclodextrin copolymer.
23 . A therapeutic composition comprising a cyclodextrin composition of claim 19 , 20 , 21 or 22 and a therapeutic agent.
24 . A method of preparing a linear cyclodextrin copolymer comprising the steps of:
copolymerizing a cyclodextrin monomer precursor, where said cyclodextrin monomer precursor is disubstituted with the same or different leaving group, with a comonomer A precursor capable of displacing said leaving groups to form a linear cyclodextrin copolymer having a repeating unit of formula Ia, Ib, or a combination thereof:
wherein C is a substituted or unsubstituted cyclodextrin monomer and A is a comonomer bound to cyclodextrin C.
25 . A method of preparing a linear cyclodextrin copolymer of claim 24 , wherein said disubstituted cyclodextrin monomer precursor is a diiodinated cyclodextrin monomer precursor of formula IVa, IVb, IVc or a mixture thereof:
26 . A method of claim 24 , wherein said cyclodextrin monomer C is an α-, β-, γ-cyclodextrin or combination thereof.
27 . A method of claim 24 , wherein said cyclodextrin monomer has the general formula (II):
and is selected from the group consisting of: 6 A ,6 B -deoxy-α-cyclodextrin (n=0, m=4), 6 A ,6 C -deoxy-α-cyclodextrin (n=1, m=3), 6 A ,6 D -deoxy-α-cyclodextrin (n=2, m=2), 6 A ,6 B -deoxy-β-cyclodextrin (n=0, m=5), 6 A ,6 C -deoxy-β-cyclodextrin (n=1, m=4), 6 A -6 D -deoxy-β-cyclodextrin (n=2, m=3), 6 A ,6 B -deoxy-γ-cyclodextrin (n=0, m=6), 6 A ,6 C -deoxy-γ-cyclodextrin (n=1, m=5), 6 A ,6 D -deoxy-γ-cyclodextrin (n=2, m=4), and 6 A ,6 E -deoxy-γ-cyclodextrin (n=3, m=3).
28 . A method of claim 24 , wherein said cyclodextrin monomer has the general formula (III):
where p=5-7.
29 . A method of claim 28 , wherein said cyclodextrin monomer is selected from the group consisting of 2 A ,3 A -dihydro-α-cyclodextrin, 2 A ,3 A -deoxy-2 A ,3 A -dihydro-β-cyclodextrin, and 2 A ,3 A -deoxy-2 A ,3 A -dihydro-γ-cyclodextrin.
30 . A method of claim 24 , wherein A is selected from the group consisting of:—
where x=1-50, and y+z=x.
31 . A method of claim 24 further comprising the step of reacting said linear cyclodextrin copolymer with a ligand to form a linear cyclodextrin copolymer having at least one ligand bound to the copolymer
32 . A method of claim 25 , further comprising the step of
aminating said diiodinated cyclodextrin monomer precursor to form a diaminated cyclodextrin monomer precursor; and copolymerizing said diaminated cyclodextrin monomer precursor to form said cyclodextrin copolymer having a repeating unit of formula Ia, Ib, or a combination thereof.
33 . A method of claim 32 , wherein said diaminated cyclodextrin monomer precursor is of formula Va, Vb, Vc or a mixture thereof:
34 . A method of claim 32 , wherein said diaminated cyclodextrin monomer precursor is of formula Vd, Ve, Vf or a mixture thereof:
35 . A method of preparing a linear cyclodextrin copolymer comprising the step of reducing a linear oxidized cyclodextrin copolymer, with the proviso that said linear oxidized cyclodextrin copolymer does not contain a reducible comonomer A.
36 . A method of preparing a linear oxidized cyclodextrin copolymer comprising the step of:
oxidizing a cyclodextrin copolymer having a repeating unit of formula Ia, Ib, or a combination thereof:
wherein C is a substituted or unsubstituted oxidized cyclodextrin monomer and A is a comonomer bound to cyclodextrin monomer C.
37 . A method of claim 34 further comprising the step of reacting said linear oxidized cyclodextrin copolymer with a ligand to form a linear oxidized cyclodextrin copolymer having at least one ligand bound to the copolymer.
38 . A method of preparing a linear oxidized cyclodextrin copolymer comprising the steps of:
(a) iodinating an oxidized cyclodextrin monomer precursor to form an oxidized diiodinated cyclodextrin monomer precursor of formula VIIa, VIIb, VIIc or a mixture thereof:
and
(b) copolymerizing said oxidized diiodinated cyclodextrin monomer precursor with a comonomer A precursor to form a linear oxidized cyclodextrin copolymer having a repeating unit of formula VIa, VIb, or a combination thereof
wherein C is a substituted or unsubstituted oxidized cyclodextrin monomer and A is a comonomer bound to the cyclodextrin monomer C.
39 . A method of claim 38 further comprising the step of reacting said linear oxidized cyclodextrin copolymer with a ligand to form a linear oxidized cyclodextrin copolymer having at least one ligand bound to the copolymer.
40 . A method of claim 38 further comprising the steps of aminating said oxidized diiodinated cyclodextrin monomer precursor to form an oxidized diaminated cyclodextrin monomer precursor of formula VIIIa, VIIIb, VIIIc or a mixture thereof:
copolymerizing said oxidized diaminated cyclodextrin monomer precursor with a comonomer A precursor to form said linear oxidized cyclodextrin copolymer having a repeating unit of formula VIa, VIb, or a combination thereof.
41 . A method of claim 38 further comprising the steps of aminating said oxidized diiodinated cyclodextrin monomer precursor to form an oxidized diaminated cyclodextrin monomer precursor of formula IXa, IXb, IXc or a mixture thereof:
42 . A method of producing a crosslinked cyclodextrin polymer comprising the step of:
reacting at least one linear cyclodextrin copolymer having a repeating unit of formula Ia, Ib, or a combination thereof:
wherein C is a substituted or unsubstituted oxidized cyclodextrin monomer and A is a comonomer bound to cyclodextrin monomer C,
with a polymer in the presence of a crosslinking agent.
43 . A method of claim 42 , wherein said polymer is a linear cyclodextrin copolymer or a linear oxidized cyclodextrin copolymer.
44 . A method of treatment comprising the step of administering a therapeutically effective amount of a therapeutic composition of claim 18 .
45 . A method of treatment comprising the step of administering a therapeutically effective amount of a therapeutic composition of claim 23 .Join the waitlist — get patent alerts
Track US2018030207A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.